Indeed, Gulati el al. observed that treatment of GBM cell lines with rapamycin not only resulted in a time-dependent decrease of S6K phosphorylation but also caused a paradoxical increase of AKT phosphorylation on serine 473 which is known to be responsible for cell proliferation. The gene discussed is AKT1; the disease is glioblastoma.